Regulators and manufacturers advance biosimilars for aflibercept, omalizumab, and dupilumab, enhancing access to treatment in ...

Kashiv BioSciences has reported encouraging topline outcomes from the randomised confirmatory trial of the proposed ...

Adults on dupilumab for severe chronic rhinosinusitis with nasal polyps had better outcomes than those who used omalizumab, ...

REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global ...

Omalizumab, a recombinant DNA-derived humanized monoclonal antibody, binds to the Cε3 domain of IgE and forms complexes that inhibit the immune system's response to allergens by averting IgE- ...

A medication called omalizumab (often sold as Xolair) has been around for a long time and was used to help deal with asthma.